Psychotropic Medication Use in Canadian Long-Term Care Patients Referred for Psychogeriatric Consultation
DOI:
https://doi.org/10.5770/cgj.v14i3.18Keywords:
antipsychotic agents, behavioral disturbances, aggression, dementia, depressionAbstract
Background and Puspose
Prior studies have shown a high prevalence of psychotropic medication use among patients residing in long-term care homes (LTCHs). The purpose of this study was to examine psychotropic medication use by LTCH patients in a metropolitan Canadian city referred to outreach teams for psychiatric assessment.
Methods
A retrospective review of charts from specialized psychogeriatric outreach teams serving a large metropolitan city in Canada was undertaken. Data from 68 charts were reviewed. Data were analyzed using descriptive and correlational statistics.
Results
Antipsychotic medications were the most frequent drugs prescribed to patients referred for psychogeriatric assessment (55.9%), followed by antidepressants (50.0%), cognitive enhancers (44.1%) and benzodiazepines (29.4%). More than a quarter of patients (26.5%) were on three psychotropic medications. Medications were adjusted in 35.3% of cases mostly resulting in dose increases. Only 5.9% of patients had their medication dose reduced.
Conclusions
This preliminary exploratory study suggests that patients referred to specialized outreach teams may be a difficult-to-treat population. Further studies are required to establish effective prescribing practices and service delivery models.
Downloads
Published
How to Cite
Issue
Section
License
Authors contributing to the Candian Geriatrics Journal retain copyright of their work, with exclusive publication rights granted to the Canadian Geriatrics Society upon article acceptance. Read the journal's full copyright and open access policy.